 5323. systemic effects of androgenic and estrogenic hormones in advanced breast cancer the systemic effects of diethylstilbestrol (45 patients), testosterone propionate (48 patients), and both hormones (22 patients) were studied during the treatment (six weeks to over three months) of advanced breast cancer in postmenopausal women.  serious complications included induced hypercalcemia and fluid retention.  physiologic effects such as urinary incontinence (diethylstilbestrol), virilization (testosterone), or nausea and vomiting did not necessitate discontinuance of treatment.  androgenic therapy stimulated erythropoiesis.  observations on the systemic reactions to these hormonal agents definitely contribute to the evaluation of sex steroid therapy. 